CRIS Current Research Information System

CALABRESE, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.817
EU - Europa 4.739
AS - Asia 1.481
AF - Africa 307
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 12.360
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.805
GB - Regno Unito 1.180
IT - Italia 950
SE - Svezia 706
DE - Germania 614
VN - Vietnam 531
CN - Cina 525
UA - Ucraina 311
IN - India 266
IE - Irlanda 232
FR - Francia 169
RU - Federazione Russa 158
CH - Svizzera 149
TG - Togo 134
ZA - Sudafrica 83
JO - Giordania 81
EE - Estonia 76
BG - Bulgaria 63
CI - Costa d'Avorio 52
BE - Belgio 32
FI - Finlandia 28
SC - Seychelles 19
NG - Nigeria 18
JP - Giappone 17
RO - Romania 17
SG - Singapore 16
IR - Iran 15
GR - Grecia 14
NL - Olanda 13
CA - Canada 11
PL - Polonia 7
BR - Brasile 6
AT - Austria 5
TR - Turchia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
HR - Croazia 4
KR - Corea 4
LB - Libano 4
UZ - Uzbekistan 4
AU - Australia 3
PT - Portogallo 3
CL - Cile 2
CZ - Repubblica Ceca 2
ES - Italia 2
HK - Hong Kong 2
IL - Israele 2
MY - Malesia 2
QA - Qatar 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
HU - Ungheria 1
ID - Indonesia 1
LK - Sri Lanka 1
MU - Mauritius 1
NO - Norvegia 1
RS - Serbia 1
Totale 12.360
Salva come PNG Salva come JPEG
Città #
Southend 1.047
Fairfield 708
Chandler 705
Ashburn 546
Wilmington 353
Woodbridge 334
Seattle 303
Houston 298
Princeton 285
Ann Arbor 265
Cambridge 238
Dublin 232
Dong Ket 223
Jacksonville 195
Bern 136
Lomé 134
Nanjing 109
Bologna 103
Westminster 102
Padova 99
Berlin 85
Amman 81
Milan 77
Turin 67
Sofia 63
San Diego 62
New York 61
Saint Petersburg 55
Abidjan 52
Jinan 51
Beijing 50
Shenyang 49
Mülheim 45
Rome 38
Changsha 32
Nanchang 31
Bremen 30
Brussels 30
Hebei 29
Medford 28
Des Moines 27
Redmond 26
Boardman 23
Helsinki 23
Washington 23
Redwood City 22
Tianjin 19
Jiaxing 18
Mahé 18
Abeokuta 17
Taizhou 17
Dearborn 16
Olalla 16
Tokyo 16
Haikou 15
Leawood 15
Norwalk 15
Zhengzhou 15
Taiyuan 14
Ningbo 13
Pesaro 13
Ferrara 12
Florence 12
Frankfurt am Main 12
London 12
San Venanzo 12
Boydton 11
Phoenix 11
Verona 11
Bühl 10
Capaccio 10
Castel Maggiore 10
Falls Church 10
Kunming 10
Cervia 9
Guangzhou 9
Lanzhou 9
Toronto 9
Catania 8
Pune 8
Castelnuovo Rangone 7
Genoa 7
Napoli 7
Costa Mesa 6
Mumbai 6
Naples 6
Amsterdam 5
Bari 5
Cesenatico 5
Dallas 5
Frankfurt Am Main 5
Genzano Di Roma 5
Hangzhou 5
Kuban 5
Los Angeles 5
Monmouth Junction 5
Paris 5
St Petersburg 5
Den Haag 4
Fremont 4
Totale 8.114
Salva come PNG Salva come JPEG
Nome #
Psychometric validation of the italian translation of the gastrointestinal symptom-rating scale and quality of life in reflux and dyspepsia questionnaire in patients with gastro-oesophageal reflux disease. 319
Ulcerative Colitis 200
COVID-19 in IBD: The experience of a single tertiary IBD center 191
Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer. 186
Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment 157
Attachment and quality of life in patients with inflammatory bowel disease 152
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 149
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 146
Erosions or not in GORD? The potential role of oesophageal cell proliferation 144
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 143
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine. 142
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 141
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 140
HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report 138
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 136
Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy. 135
Differential activity and expression of superoxide dismutase in human gastric neoplasm 133
Acute Esophageal Necrosis. 133
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 133
Risk of duodenal adenomas in familial adenomatous polyposis to progress toward advanced neoplastic disease 132
Endoscopic appearance of GERD: Putative role of cell proliferation 131
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 130
Clinical course of microscopic colitis in a single-center cohort study 129
Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn’s Disease 129
Management and treatment of distal ulcerative colitis 128
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 127
Superoxide dismutase in gastric adenocarcinoma: is it a clinical biomarker in the development of cancer? 125
Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux 124
Esophageal cell proliferation in gastroesophageal reflux disease: clinical-morphological data before and after pantoprazole. 124
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 123
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 122
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 122
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 121
Extramedullary myeloid tumour of the stomach and duodenum presenting without acute myeloblastic leukemia: a diagnostic and therapeutic challenge. 120
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. 119
High-dose probiotics for the treatment of active pouchitis 118
Antibiotics and probiotics in treatment of inflammatory bowel disease 118
Capsule endoscopy revealing small-intestinal lymphangiectasia and GI stromal tumor polyps in neurofibromatosis type 1. 116
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. 115
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 114
Identification of mobile lipids in human cancer tissues by ex vivo diffusion edited HR-MAS MRS 112
Implications of antioxidant enzymes in human gastric neoplasms 112
Burden of illness in Italian patients with gastro-oesophageal reflux disease 112
Ex vivo HR-MAS Magnetic Resonance Spectroscopy of human gastric adenocarcinomas: a comparison with healthy gastric mucosa 110
Mesalazine with or without cholestyramine in the treatment of microscopic colitis: Randomized controlled trial 110
Oral budesonide in the treatment of chronic refractory pouchitis. 110
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 110
Urease-Positive Bacteria Other than Helicobacter pylori in Human Gastric Juice and Mucosa 109
Role of conventional therapies in the era of biological treatment in Crohn's disease. 109
Long-term management of GERD in the elderly with pantoprazole 107
Discrimination of Healthy and Neoplastic Human Colon Tissues by ex Vivo HR-MAS NMR Spectroscopy and Chemometric Analyses 107
Oral beclomethasone dipropionate in chronic refractory pouchitis 107
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 107
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 106
Which therapies are advisable in pouchitis? 105
The role of Budesonide-MMX in active ulcerative colitis. 104
Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy. 102
Probiotics, Prebiotics, and Antibiotics in IBD 100
Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis. 100
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 99
Colitis evolving into ulcerative colitis 98
THE ROLE OF SOD, CAT AND CYP1A1/1A2 IN HUMAN GASTRIC NEOPLASM   97
Pre-pouch ileitis 97
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation 97
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 97
Erosions or not in GERD? The potential role of esophageal cell kinetics 96
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. 96
Cytochrome P450 (CYP1A/1A2)and SODs expression in human gastric neoplasm 94
Cytochrome P450 (CYP 1A1/1A2) expression and lipid profile in human gastric neoplasm 94
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis 94
Probiotics in IBD: A critical review 94
Bifidobacteriaceae usually colonize human hypochloridric stomach 92
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 92
Molecular characterization of human gastric mucosa by HR-MAS magnetic resonance spectroscopy 91
Rescue therapy: ciclosporin or infliximab? 91
Cytochrome P450 (CYP 1A1/1A2) and SODs expression in human gastric neoplasm 89
The role of antibiotics and probiotics in pouchitis 87
Role of Biologics in refractory pouchitis 86
Risk of permanent stoma in extensive Crohn's colitis: The impact of biological drugs 85
null 84
Cancer surveillance in ulcerative colitis: Critical analysis of long-term prospective programme 84
RISK OF SHORT TERM POSTOPERATIVE COMPLICATIONS IN PATIENTS TREATED WITH AZATHIOPRINE FOR CROHN'S DISEASE. A SINGLE CENTRE EXPERIENCE 83
null 83
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 82
The safety of beclomethasone dipropionate in the treatment of ulcerative colitis 82
Budesonide MMX: efficacy and safety profile in the treatment of ulcerative colitis 81
Occurrence of Bifidobacteriaceae in human hypochlorhydria stomach 79
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 77
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 76
Inflammatory bowel diseases and spondyloarthropathies 76
Timing and protocols of clinical and endoscopic surveillance of Barrett's esophagus 75
Implications of antioxidant protein in human gastric neoplasm 72
THE RISK OF DUODENAL CANCER IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) 69
EFFICACY, SAFETY, IMPACT ON NATURAL HISTORY OF LONG TERM TREATMENT WITH THIOPURINES IN CROHN'S DISEASE PATIENTS. A SINGLE CENTER EXPERIENCE 68
Superoxide dismutase expression in gastric adenocarcinoma: a clinical biomarker in the development of cancer. 68
Risk of duodenal cancer in patients with familial adenomatous polyposis 66
Cell proliferation of the duodenal mucosa in patients affected by familial adenomatous polyposis 66
Dilated intercellular spaces as a marker of oesophageal damage: Comparative results in gastro-oesophageal reflux disease with or without bile reflux 66
Discrimination of healthy and neoplastic human colon tissues by ex vivo HR-MAS NMR Spectroscopy and chemometric analyses. 65
ORAL BECLOMETHASONE DIPROPIONATE IN THE TREATMENT OF CHRONIC REFRACTORY POUCHITIS 65
Totale 11.077
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.959
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019170 0 0 0 0 0 0 0 0 0 0 57 113
2019/20202.963 458 63 49 190 274 306 331 387 392 210 132 171
2020/20211.965 362 86 36 98 58 83 49 107 210 130 85 661
2021/20222.611 210 88 182 181 251 140 66 172 103 193 628 397
2022/20233.153 286 454 156 375 219 254 109 168 577 59 233 263
2023/2024890 65 154 86 77 72 228 60 44 23 56 25 0
Totale 12.701